1. Home
  2. IART vs EOS Comparison

IART vs EOS Comparison

Compare IART & EOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

N/A

Current Price

$9.46

Market Cap

744.3M

Sector

Health Care

ML Signal

N/A

Logo Eaton Vance Enhance Equity Income Fund II

EOS

Eaton Vance Enhance Equity Income Fund II

N/A

Current Price

$21.72

Market Cap

1.2B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IART
EOS
Founded
1989
N/A
Country
United States
United States
Employees
4427
N/A
Industry
Medical/Dental Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
744.3M
1.2B
IPO Year
1996
2004

Fundamental Metrics

Financial Performance
Metric
IART
EOS
Price
$9.46
$21.72
Analyst Decision
Hold
Analyst Count
7
0
Target Price
$14.83
N/A
AVG Volume (30 Days)
730.0K
112.8K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.45
N/A
Revenue Next Year
$3.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.26
$17.56
52 Week High
$23.27
$24.49

Technical Indicators

Market Signals
Indicator
IART
EOS
Relative Strength Index (RSI) 28.33 41.84
Support Level N/A $21.64
Resistance Level $14.14 $23.44
Average True Range (ATR) 0.54 0.29
MACD -0.17 -0.01
Stochastic Oscillator 3.87 49.51

Price Performance

Historical Comparison
IART
EOS

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

About EOS Eaton Vance Enhance Equity Income Fund II

Eaton Vance Enhanced Equity Income Fund II is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income, with a secondary objective of capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in common stocks. It invests in a portfolio of large and mid-cap securities in sectors such as Information Technology, Consumer Discretionary, Communication Services, Healthcare, Industrials, Consumer Staples, Financials, Materials, and Energy.

Share on Social Networks: